News

Initially, Dr Reddy's will focus on launching the generic semaglutide in Canada, India, Brazil, Turkey, and other emerging ...
Gut health is finally becoming cool, which means more brands are touting the fiber available in their products.
People who stop taking GLP-1 medications like Ozempic and Wegovy started to regain weight in a short amount of time, ...
The researchers first tested their hypothesis by delivering ODN directly to the hindbrain of rats. Once treated, the rats ...
While we’ll not yet at the stage of clearing the beaches and hiring Quint, there are definite signs of meme stocks circling.
Amanda Bynes, Lizzo, Oprah and other Hollywood celebs get candid about their weight loss journey including drugs used to support them slimming down faster.
Viatris Inc.'s proposed copy of Novo Nordisk A/S’ Wegovy doesn’t infringe a patent on using the once-weekly obesity drug ...
Dr Reddy's Laboratories plans to launch a cheaper copycat version of Novo Nordisk's blockbuster weight-loss drug Wegovy in 87 ...
Dr Reddy's Laboratories plans to launch a cheaper copycat version of Novo Nordisk's blockbuster weight-loss drug Wegovy in 87 ...
Dr. Reddy’s Laboratories ( NYSE: RDY) is preparing to launch a generic version of semaglutide, the active ingredient in Novo ...
Older adults and women using Wegovy for obesity management may be more likely to lose lean mass, although increasing protein intake may help protect against lean mass loss, according to a speaker.
The hormonal changes of menopause can make the weight gain more resistant to traditional diet and lifestyle changes. But GLP-1s can be an effective reinforcement of diet and exercise.